These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 28333917)

  • 1. A clinical utility study of exome sequencing versus conventional genetic testing in pediatric neurology.
    Vissers LELM; van Nimwegen KJM; Schieving JH; Kamsteeg EJ; Kleefstra T; Yntema HG; Pfundt R; van der Wilt GJ; Krabbenborg L; Brunner HG; van der Burg S; Grutters J; Veltman JA; Willemsen MAAP
    Genet Med; 2017 Sep; 19(9):1055-1063. PubMed ID: 28333917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole exome sequencing in neurogenetic odysseys: An effective, cost- and time-saving diagnostic approach.
    Córdoba M; Rodriguez-Quiroga SA; Vega PA; Salinas V; Perez-Maturo J; Amartino H; Vásquez-Dusefante C; Medina N; González-Morón D; Kauffman MA
    PLoS One; 2018; 13(2):e0191228. PubMed ID: 29389947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole Exome Sequencing in Pediatric Neurology Patients: Clinical Implications and Estimated Cost Analysis.
    Nolan D; Carlson M
    J Child Neurol; 2016 Jun; 31(7):887-94. PubMed ID: 26863999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic Impact and Cost-effectiveness of Whole-Exome Sequencing for Ambulant Children With Suspected Monogenic Conditions.
    Tan TY; Dillon OJ; Stark Z; Schofield D; Alam K; Shrestha R; Chong B; Phelan D; Brett GR; Creed E; Jarmolowicz A; Yap P; Walsh M; Downie L; Amor DJ; Savarirayan R; McGillivray G; Yeung A; Peters H; Robertson SJ; Robinson AJ; Macciocca I; Sadedin S; Bell K; Oshlack A; Georgeson P; Thorne N; Gaff C; White SM
    JAMA Pediatr; 2017 Sep; 171(9):855-862. PubMed ID: 28759686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost-effectiveness of whole-exome sequencing in progressive neurological disorders of children.
    Aaltio J; Hyttinen V; Kortelainen M; Frederix GWJ; Lönnqvist T; Suomalainen A; Isohanni P
    Eur J Paediatr Neurol; 2022 Jan; 36():30-36. PubMed ID: 34852981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of whole-exome sequencing and costs of the traditional diagnostic trajectory in children with intellectual disability.
    Monroe GR; Frederix GW; Savelberg SM; de Vries TI; Duran KJ; van der Smagt JJ; Terhal PA; van Hasselt PM; Kroes HY; Verhoeven-Duif NM; Nijman IJ; Carbo EC; van Gassen KL; Knoers NV; Hövels AM; van Haelst MM; Visser G; van Haaften G
    Genet Med; 2016 Sep; 18(9):949-56. PubMed ID: 26845106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reanalysis of whole-exome sequencing (WES) data of children with neurodevelopmental disorders in a standard patient care context.
    van Slobbe M; van Haeringen A; Vissers LELM; Bijlsma EK; Rutten JW; Suerink M; Nibbeling EAR; Ruivenkamp CAL; Koene S
    Eur J Pediatr; 2024 Jan; 183(1):345-355. PubMed ID: 37889289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positioning whole exome sequencing in the diagnostic pathway for rare disease to optimise utility: a protocol for an observational cohort study and an economic evaluation.
    Hayeems RZ; Bernier F; Boycott KM; Hartley T; Michaels-Igbokwe C; Marshall DA
    BMJ Open; 2022 Oct; 12(10):e061468. PubMed ID: 36216418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bayesian cost-effectiveness analysis of Whole genome sequencing versus Whole exome sequencing in a pediatric population with suspected genetic disorders.
    Nurchis MC; Radio FC; Salmasi L; Heidar Alizadeh A; Raspolini GM; Altamura G; Tartaglia M; Dallapiccola B; Damiani G
    Eur J Health Econ; 2024 Aug; 25(6):999-1011. PubMed ID: 37975990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrating exome sequencing into a diagnostic pathway for epileptic encephalopathy: Evidence of clinical utility and cost effectiveness.
    Palmer EE; Schofield D; Shrestha R; Kandula T; Macintosh R; Lawson JA; Andrews I; Sampaio H; Johnson AM; Farrar MA; Cardamone M; Mowat D; Elakis G; Lo W; Zhu Y; Ying K; Morris P; Tao J; Dias KR; Buckley M; Dinger ME; Cowley MJ; Roscioli T; Kirk EP; Bye A; Sachdev RK
    Mol Genet Genomic Med; 2018 Mar; 6(2):186-199. PubMed ID: 29314763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exome Sequencing for Isolated Congenital Hearing Loss: A Cost-Effectiveness Analysis.
    Downie L; Amor DJ; Halliday J; Lewis S; Martyn M; Goranitis I
    Laryngoscope; 2021 Jul; 131(7):E2371-E2377. PubMed ID: 33382469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid exome sequencing as a first-tier test in neonates with suspected genetic disorder: results of a prospective multicenter clinical utility study in the Netherlands.
    Olde Keizer RACM; Marouane A; Kerstjens-Frederikse WS; Deden AC; Lichtenbelt KD; Jonckers T; Vervoorn M; Vreeburg M; Henneman L; de Vries LS; Sinke RJ; Pfundt R; Stevens SJC; Andriessen P; van Lingen RA; Nelen M; Scheffer H; Stemkens D; Oosterwijk C; van Amstel HKP; de Boode WP; van Zelst-Stams WAG; Frederix GWJ; Vissers LELM;
    Eur J Pediatr; 2023 Jun; 182(6):2683-2692. PubMed ID: 36997769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic Yield and Economic Implications of Whole-Exome Sequencing for ASD Diagnosis in Israel.
    Tal-Ben Ishay R; Shil A; Solomon S; Sadigurschi N; Abu-Kaf H; Meiri G; Flusser H; Michaelovski A; Dinstein I; Golan H; Davidovitch N; Menashe I
    Genes (Basel); 2021 Dec; 13(1):. PubMed ID: 35052376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Results of Whole Exome Sequencing Performed On Previously Undiagnosed Pediatric Neurology Patients.
    Ahmadnia N; Beiraghi Toosi M; Ghayour Karimiani E; Ashrafzadeh F; Faraji Rad M
    Iran J Child Neurol; 2021; 15(2):17-31. PubMed ID: 36213152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The diagnostic pathway in complex paediatric neurology: a cost analysis.
    van Nimwegen KJ; Schieving JH; Willemsen MA; Veltman JA; van der Burg S; van der Wilt GJ; Grutters JP
    Eur J Paediatr Neurol; 2015 Mar; 19(2):233-9. PubMed ID: 25604808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-Effectiveness of Whole-Genome vs Whole-Exome Sequencing Among Children With Suspected Genetic Disorders.
    Nurchis MC; Radio FC; Salmasi L; Heidar Alizadeh A; Raspolini GM; Altamura G; Tartaglia M; Dallapiccola B; Pizzo E; Gianino MM; Damiani G
    JAMA Netw Open; 2024 Jan; 7(1):e2353514. PubMed ID: 38277144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exome sequencing has higher diagnostic yield compared to simulated disease-specific panels in children with suspected monogenic disorders.
    Dillon OJ; Lunke S; Stark Z; Yeung A; Thorne N; ; Gaff C; White SM; Tan TY
    Eur J Hum Genet; 2018 May; 26(5):644-651. PubMed ID: 29453417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic value of whole-exome sequencing in Chinese pediatric-onset neuromuscular patients.
    Tsang MHY; Chiu ATG; Kwong BMH; Liang R; Yu MHC; Yeung KS; Ho WHL; Mak CCY; Leung GKC; Pei SLC; Fung JLF; Wong VCN; Muntoni F; Chung BHY; Chan SHS
    Mol Genet Genomic Med; 2020 May; 8(5):e1205. PubMed ID: 32154989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective comparison of the cost-effectiveness of clinical whole-exome sequencing with that of usual care overwhelmingly supports early use and reimbursement.
    Stark Z; Schofield D; Alam K; Wilson W; Mupfeki N; Macciocca I; Shrestha R; White SM; Gaff C
    Genet Med; 2017 Aug; 19(8):867-874. PubMed ID: 28125081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical whole-exome sequencing results impact medical management.
    Niguidula N; Alamillo C; Shahmirzadi Mowlavi L; Powis Z; Cohen JS; Farwell Hagman KD
    Mol Genet Genomic Med; 2018 Nov; 6(6):1068-1078. PubMed ID: 30318729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.